We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00322790
Recruitment Status : Withdrawn
First Posted : May 8, 2006
Last Update Posted : April 3, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females.

Condition or disease
Cancer

Detailed Description:
Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study.

Study Design

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: INST 0549C Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study
Study Start Date : January 2006
Estimated Primary Completion Date : January 2010
Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals diagnosed with malignant germ cell tumors at University of New Mexico facilities
Criteria

Inclusion Criteria:

  • Survival for Malignant Germ Cell Tumors in Males and Females.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00322790


Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87114
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico
More Information

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00322790     History of Changes
Other Study ID Numbers: INST 0549C
First Posted: May 8, 2006    Key Record Dates
Last Update Posted: April 3, 2015
Last Verified: March 2015

Additional relevant MeSH terms:
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms